三氧化二砷隔日给药治疗急性早幼粒细胞白血病的临床观察
CHINESE JOURNAL OF HEMATOLOGY(2005)
Abstract
三氧化二砷(As2O3)10 mg每日1次静脉点滴(静点)已成为急性早幼粒细胞白血病(APL)的首选治疗方案,但也有个别患者因不良反应中断治疗[1].我们采用As2O310 mg静脉隔日给药,并用原子荧光法监测血砷浓度,以观察小剂量As2O3的临床疗效及不良反应.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined